
Milestone Pharmaceuticals MIST
€ 0.70
0.25%
Milestone Pharmaceuticals P/E | MIST
P/E Jährlich Milestone Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.29 K | -1.75 K | -875 | -2.06 | -4.84 | -2.33 | -6.29 | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -2.06 | -2.29 K | -704 |
P/E anderer Aktien in der Pharmaeinzelhändler
| Name | P/E | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Madrigal Pharmaceuticals
MDGL
|
-34.3 | $ 493.62 | 0.1 % | $ 11.1 B | ||
|
MediWound Ltd.
MDWD
|
-14.3 | $ 13.51 | 0.22 % | $ 368 M | ||
|
Mesoblast Limited
MESO
|
-22.4 | $ 14.22 | 0.99 % | $ 17.2 B | ||
|
MacroGenics
MGNX
|
-2 K | $ 3.77 | 5.31 % | $ 238 M | ||
|
MeiraGTx Holdings plc
MGTX
|
-5.7 | $ 10.92 | 1.2 % | $ 878 M | ||
|
Mirum Pharmaceuticals
MIRM
|
-233 | $ 81.43 | 0.07 % | $ 4.09 B | ||
|
MannKind Corporation
MNKD
|
169 | $ 3.82 | 0.53 % | $ 1.17 B | ||
|
MediciNova
MNOV
|
5.77 | $ 1.76 | 0.28 % | $ 86.4 M | ||
|
Monopar Therapeutics
MNPR
|
-29.2 | $ 78.29 | 0.41 % | $ 580 M | ||
|
Mereo BioPharma Group plc
MREO
|
-0.391 | $ 0.39 | 2.16 % | $ 311 M | ||
|
Merck & Co.
MRK
|
17 | $ 139.54 | 0.34 % | $ 349 B | ||
|
Marker Therapeutics
MRKR
|
-1.69 | $ 1.06 | 0.95 % | $ 16.2 M | ||
|
Moderna
MRNA
|
-6.88 | $ 203.21 | 6.95 % | $ 79 B | ||
|
Maravai LifeSciences Holdings
MRVI
|
-2.35 | $ 8.52 | 7.85 % | $ 1.23 B | ||
|
Matinas BioPharma Holdings
MTNB
|
-0.265 | $ 2.82 | 6.82 % | $ 15.4 M | ||
|
RAPT Therapeutics
RAPT
|
-0.364 | - | - | $ 2.36 B | ||
|
Neurocrine Biosciences
NBIX
|
34.9 | $ 144.21 | 0.72 % | $ 14.3 B | ||
|
Nanobiotix S.A.
NBTX
|
-60.6 K | $ 25.1 | 0.16 % | $ 1.2 T | ||
|
NuCana plc
NCNA
|
-2.91 K | $ 1.06 | 2.75 % | $ 11.9 B | ||
|
Minerva Neurosciences
NERV
|
-0.211 | $ 3.32 | 1.22 % | $ 28.1 M | ||
|
Nektar Therapeutics
NKTR
|
-6.67 | $ 42.22 | 2.2 % | $ 712 M | ||
|
Nkarta
NKTX
|
-1.51 | $ 2.53 | 0.59 % | $ 187 M | ||
|
NanoViricides
NNVC
|
-3.68 | $ 1.45 | 13.28 % | $ 29.3 M | ||
|
Nurix Therapeutics
NRIX
|
-5.93 | $ 22.88 | 0.09 % | $ 1.98 B | ||
|
Nuvation Bio
NUVB
|
-9.73 | $ 4.95 | 1.07 % | $ 1.69 B | ||
|
Novavax
NVAX
|
4.19 | $ 12.56 | 20.08 % | $ 2.03 B | ||
|
Novo Nordisk A/S
NVO
|
2.14 | $ 37.54 | 0.59 % | $ 167 B | ||
|
Novartis AG
NVS
|
22.6 | $ 140.93 | 0.01 % | $ 273 B | ||
|
NextCure
NXTC
|
-0.645 | $ 5.05 | 0.59 % | $ 14.4 M | ||
|
Ocugen
OCGN
|
-9.05 | $ 1.04 | 1.96 % | $ 325 M | ||
|
Ocular Therapeutix
OCUL
|
-6.42 | $ 7.25 | 4.17 % | $ 1.36 B | ||
|
Oragenics
OGEN
|
-1.75 | $ 0.49 | 1.25 % | $ 1.06 M | ||
|
Olema Pharmaceuticals
OLMA
|
-8.89 | $ 8.25 | 0.3 % | $ 718 M | ||
|
Omeros Corporation
OMER
|
-200 | $ 18.9 | 1.56 % | $ 1.2 B | ||
|
Oncolytics Biotech
ONCY
|
-1.52 | $ 0.6 | 1.21 % | $ 57.5 M | ||
|
ORIC Pharmaceuticals
ORIC
|
-7.89 | $ 12.49 | 2.34 % | $ 1.1 B | ||
|
Oramed Pharmaceuticals
ORMP
|
2.15 | $ 4.55 | 1.34 % | $ 188 M | ||
|
Outlook Therapeutics
OTLK
|
-0.987 | $ 0.6 | 0.42 % | $ 20.9 M | ||
|
Ovid Therapeutics
OVID
|
-17.2 | $ 2.34 | 0.21 % | $ 305 M | ||
|
Passage Bio
PASG
|
-2.48 | $ 4.09 | 0.73 % | $ 13.1 M | ||
|
Puma Biotechnology
PBYI
|
12.2 | $ 9.67 | 1.68 % | $ 484 M | ||
|
Processa Pharmaceuticals
PCSA
|
-0.305 | $ 1.49 | 0.62 % | $ 1.95 M | ||
|
Vaxcyte
PCVX
|
-10.9 K | $ 73.82 | 30.7 % | $ 10 B | ||
|
PDS Biotechnology Corporation
PDSB
|
-3.31 | $ 1.2 | 60.32 % | $ 55.7 M | ||
|
Pfizer
PFE
|
19.9 | $ 27.41 | 0.02 % | $ 156 B | ||
|
Precigen
PGEN
|
-3.87 | $ 7.74 | 4.02 % | $ 2.42 B | ||
|
Pharming Group N.V.
PHAR
|
26.3 | $ 9.8 | 0.51 % | $ 6.75 B | ||
|
Phathom Pharmaceuticals
PHAT
|
-4.46 K | $ 6.7 | 1.77 % | $ 489 M | ||
|
Phio Pharmaceuticals Corp.
PHIO
|
-0.812 | $ 0.99 | 0.6 % | $ 5.92 M |